High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 2, 2012, Pages 869-874

  Burgel, Pierre Régis ^a,b   Baixench, Marie Thérèse ^a,b   Amsellem, Michaël ^a,b   Audureau, Etienne ^a,c   Chapron, Jeanne ^a,b   Kanaan, Reem ^a,b   Honoré, Isabelle ^a,b   Dupouy Camet, Jean ^a,b   Dusser, Daniel ^a,b   Klaassen, Corné H ^d   Meis, Jacques F ^d,e   Hubert, Dominique ^a,b   Paugam, André ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b AP HP ^*  (France)

^c HÔTEL DIEU   (France)

^d CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE;

ADULT; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ARTICLE; ASPERGILLOSIS; BACTERIUM ISOLATION; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG RESISTANCE; DRUG SENSITIVITY; EPSILOMETER TEST; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SPUTUM ANALYSIS;

ADULT; ANTIFUNGAL AGENTS; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS FUMIGATUS; AZOLES; COHORT STUDIES; CYSTIC FIBROSIS; DRUG RESISTANCE, FUNGAL; FEMALE; HUMANS; ITRACONAZOLE; MALE; MICROBIAL SENSITIVITY TESTS; PREVALENCE; SPUTUM; YOUNG ADULT;

EID: 84856074224     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05077-11     Document Type: Article

References (27)

1. Alanio A, et al. 2011. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for fast and accurate identification of clinically relevant Aspergillus species. Clin. Microbiol. Infect. 17:750-755.
2. Alanio A, et al. 2011. Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies. J. Antimicrob. Chemother. 66:371-374.
3. Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Cuenca-Estrella M, Rodriguez-Tudela JL. 2008. Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification. Antimicrob. Agents Chemother. 52:1244-1251. (Pubitemid 351521983)
4. Amin R, Dupuis A, Aaron SD, Ratjen F. 2010. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest 137:171-176.
5. Amorim A, Guedes-Vaz L, Araujo R. 2010. Susceptibility to five antifungals of Aspergillus fumigatus strains isolated from chronically colonised cystic fibrosis patients receiving azole therapy. Int. J. Antimicrob. Agents 35:396-399.
6. Arendrup MC, et al. 2010. Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence. PLoS One 5:e10080.
7. Billaud EM, et al. 2010. Pharmacological considerations for azole antifungal drug management in cystic fibrosis lung transplant patients. Med. Mycol. 48(Suppl. 1):S52-S59.
8. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi-second edition: approved standard M38-A2.CLSI, Wayne, PA.
9. de Valk HA, et al. 2009. Molecular typing and colonization patterns of Aspergillus fumigatus in patients with cystic fibrosis. J. Cyst. Fibros. 8:110-114.
10. de Vrankrijker AM, et al. 2011. Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function? Clin. Microbiol. Infect. 17:1381-1386.
11. Farrell PM, et al. 2008. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J. Pediatr. 153:S4-S14. (Pubitemid 351970581)
12. Hilliard T, et al. 2005. Voriconazole therapy in children with cystic fibrosis. J. Cyst. Fibros. 4:215-220. (Pubitemid 43013027)
13. Horré R, Symoens F, Delhaes L, Bouchara JP. 2010. Fungal respiratory infections in cystic fibrosis: a growing problem. Med. Mycol. 48(Suppl. 1):S1-S3.
14. Howard SJ, Arendrup MC. 2011. Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection. Med. Mycol. 49(Suppl. 1):S90-S95.
15. Howard SJ, et al. 2009. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg. Infect. Dis. 15:1068-1076.
16. Iversen M, et al. 2007. Aspergillus infection in lung transplant patients: incidence and prognosis. Eur. J. Clin. Microbiol. Infect. Dis. 26:879-886. (Pubitemid 350077208)
17. Klaassen CH, De Valk HA, Curfs-Breuker IM, Meis JF. 2010. Novel mixed-format real-time PCR assay to detect mutations conferring resistance triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical isolates in the Netherlands. J. Antimicrob. Chemother. 65:901-905.
18. Mortensen KL, et al. 2011. Aspergillus species and other moulds in respiratory samples from cystic fibrosis patients: a laboratory-based study with focus on azole resistance in Aspergillus fumigatus. J. Clin. Microbiol. 49:2243-2251.
19. Paugam A, et al. 2010. Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in France. Med. Mycol. 48(Suppl. 1):S32-S36.
20. Rodriguez-Tudela JL, et al. 2008. Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus. Antimicrob. Agents Chemother. 52:2468-2472. (Pubitemid 351915677)
21. Rodriguez-Tudela JL, et al. 2008. EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin. Microbiol. Infect. 14:398-405. (Pubitemid 351356536)
22. Shoseyov D, Brownlee KG, Conway SP, Kerem E. 2006. Aspergillus bronchitis in cystic fibrosis. Chest 130:222-226. (Pubitemid 44116864)
23. Snelders E, et al. 2008. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med. 5:e219.
24. Stevens DA, et al. 2003. Allergic bronchopulmonary aspergillosis in cystic fibrosis-state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin. Infect. Dis. 37(Suppl. 3):S225-S264. (Pubitemid 37260463)
25. Terpstra PD, et al. 2011. Filamentous fungi in the Netherlands among CF patients. Mycoses 54(Suppl. 2):152.
26. Verweij PE, Howard SJ, Melchers WJ, Denning DW. 2009. Azole-resistance in Aspergillus: proposed nomenclature and breakpoints. Drug Resist. Updat. 12:141-147.
27. Verweij PE, Snelders E, Kema GH, Mellado E, Melchers WJ. 2009. Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? Lancet Infect. Dis. 9:789-795.